Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
UTC Therapeutics Inc.
Weprom
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
SpeciCare
Instituto do Cancer do Estado de São Paulo
SPGO Research Mannheim GmbH
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)